James Crowe
Faculty Member
Last active: 3/31/2020

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.

Broeckel R, Fox JM, Haese N, Kreklywich CN, Sukulpovi-Petty S, Legasse A, Smith PP, Denton M, Corvey C, Krishnan S, Colgin LMA, Ducore RM, Lewis AD, Axthelm MK, Mandron M, Cortez P, Rothblatt J, Rao E, Focken I, Carter K, Sapparapau G, Crowe JE, Diamond MS, Streblow DN
PLoS Negl Trop Dis. 2017 11 (6): e0005637

PMID: 28628616 · PMCID: PMC5491320 · DOI:10.1371/journal.pntd.0005637

MeSH Terms (12)

Animals Antibodies, Monoclonal Antibodies, Viral B-Lymphocytes Chikungunya Fever Chikungunya virus Disease Models, Animal Drug Evaluation, Preclinical Immunologic Factors Macaca mulatta T-Lymphocytes Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: